US EditionPublished • loading... • Updated
Latest opioid settlement plan with OxyContin maker Purdue and Sackler family getting few objections
The settlement includes up to $7 billion in Sackler family payments and $850 million for individuals, aiming to fund opioid crisis mitigation and end years of litigation.
- Lawyers representing OxyContin maker Purdue Pharma, the Sackler family, and others across the U.S. are expected to urge a bankruptcy court judge to approve a plan to settle thousands of opioid-related lawsuits against the company.
- If approved, the plan would close a long legal battle over Purdue's role in the opioid crisis that has caused 900,000 deaths in the U.S. since 1999.
- The Sackler family members would be required to pay up to $7 billion and give up ownership of Purdue, which would get a new name and dedicate future profits to battling the opioid crisis.
Insights by Ground AI
36 Articles
36 Articles
Associated Press News+35 Reposted by 35 other sources
Latest opioid settlement plan with OxyContin maker Purdue and Sackler family getting few objections
The company that makes OxyContin, members of the Sackler family who own it and many groups that sued over its role in the opioid crisis are asking a judge to approve a settlement plan.
·United States
Read Full ArticleCoverage Details
Total News Sources36
Leaning Left9Leaning Right5Center17Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
L 29%
C 55%
R 16%
Factuality
To view factuality data please Upgrade to Premium
